• Madrigal Pharmaceuticals director Richard S. Levy sold 5,642 shares of common stock on May 22, 2026.
• Sales were executed at weighted average prices ranging from $506.68 to $519.98 per share.
• Levy held 22,015 shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Madrigal Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-037830), on May 22, 2026, and is solely responsible for the information contained therein.